tiprankstipranks
Advertisement
Advertisement
Crispr Therapeutics price target raised to $82 from $80 at Citi
PremiumThe FlyCrispr Therapeutics price target raised to $82 from $80 at Citi
28d ago
Crispr Therapeutics price target lowered to $83 from $86 at BofA
Premium
The Fly
Crispr Therapeutics price target lowered to $83 from $86 at BofA
1M ago
CRISPR Therapeutics Retains Buy Rating on Casgevy Momentum and 2026 Pipeline Catalysts Despite Price Target Trim to $83
Premium
Ratings
CRISPR Therapeutics Retains Buy Rating on Casgevy Momentum and 2026 Pipeline Catalysts Despite Price Target Trim to $83
1M ago
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
PremiumMarket NewsIHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
3M ago
Crispr Therapeutics price target raised to $110 from $105 at Piper Sandler
Premium
The Fly
Crispr Therapeutics price target raised to $110 from $105 at Piper Sandler
3M ago
Crispr Therapeutics Completes $600 Million Convertible Notes Offering
Premium
Company Announcements
Crispr Therapeutics Completes $600 Million Convertible Notes Offering
3M ago
Crispr Therapeutics prices upsized convertible senior notes offering
PremiumThe FlyCrispr Therapeutics prices upsized convertible senior notes offering
3M ago
Cathie Wood’s ARK Investment buys 281K shares of Crispr Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment buys 281K shares of Crispr Therapeutics today
3M ago
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Portfolio Diversification to Investors
Premium
Market News
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Portfolio Diversification to Investors
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100